Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment

BACKGROUND: Pediatric heart failure (HF) patients have a suboptimal response to traditional HF medications, although phosphodiesterase-3 inhibition (PDE3i) has been used with greater success than in the adult HF population. We hypothesized that molecular alterations specific to children with HF and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Card Fail
Main Authors: NAKANO, STEPHANIE J., SUCHAROV, JULIANA, VAN DUSEN, ROBERT, CECIL, MACKENZIE, NUNLEY, KARIN, WICKERS, SEAN, KARIMPUR-FARD, ANIS, STAUFFER, BRIAN L., MIYAMOTO, SHELLEY D., SUCHAROV, CARMEN C.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384997/
https://ncbi.nlm.nih.gov/pubmed/27427220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2016.07.429
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki